Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

VBIV VBI Vaccines Inc

0.0559 (8.96%)
Dec 06 2023 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 54,308
Bid Price 0.651
Ask Price 0.688
News -
Day High 0.6785


52 Week Range


Day Low 0.6301
Company Name Stock Ticker Symbol Market Type
VBI Vaccines Inc VBIV NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0559 8.96% 0.6799 20:00:00
Open Price Low Price High Price Close Price Prev Close
0.647 0.6301 0.6785 0.679 0.624
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
346 54,308 $ 0.6625823 $ 35,984 - 0.45 - 21.00
Last Trade Time Type Quantity Stock Price Currency
19:28:23 formt 200 $ 0.6799 USD

VBI Vaccines Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
15.87M 23.69M - 1.08M -113.3M -4.78 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

VBI Vaccines News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No VBIV Message Board. Create One! See More Posts on VBIV Message Board See More Message Board Posts

Historical VBIV Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.6130.67850.600.614882259,1750.066910.91%
1 Month0.6360.75990.520.6199134163,2150.04396.9%
3 Months1.101.120.450.6746611201,589-0.4201-38.19%
6 Months2.763.470.451.95757,900-2.08-75.37%
1 Year14.47821.000.456.53887,144-13.80-95.3%
3 Years97.458144.900.4571.372,345,762-96.78-99.3%
5 Years51.30217.200.4574.473,559,252-50.62-98.67%

VBI Vaccines Description

VBI Vaccines Inc is a US-based commercial-stage, the biopharmaceutical company which is engaged in developing next-generation vaccines to address unmet needs in infectious disease and immuno-oncology. The company manufactures Sci-B-Vac product which is a hepatitis B (HBV) vaccine for adults, children, and newborns. Its products include Virus-Like Particle which is vaccine platform which allows for the design of enveloped virus-like particle vaccines that closely mimic the target viruses. The company operates through the single segment being Developing vaccines to address unmet needs in infectious disease and immuno-oncology.

Your Recent History

Delayed Upgrade Clock